Table 1.
Subjects' Demographic Data at Study Entry
| Study population (n = 74) | |
|---|---|
| Male sex [No. (%)] | 61 (82) |
| Race | |
| African American [No. (%)] | 55 (74) |
| White [No. (%)] | 17 (23) |
| Hispanic [No. (%)] | 2 (3) |
| †On LPV/r tablet at entry | |
| No [No. (%)] | 49 (66) |
| Yes [No. (%)] | 25 (34) |
| On anti-diarrheal drug | |
| No [No. (%)] | 67 (92) |
| Yes [No. (%)] | 6 (8) |
| On lipid lowering drug | |
| No [No. (%)] | 54 (74) |
| Yes [No. (%)] | 19 (26) |
| Median age [years (IQR)] | 43 (39-47) |
| Median weight [Kg (IQR)] | 80.5 (69.60-88.60) |
| Median HIV-1 RNA [copies/ml (IQR)] | 0.135 (0.05-0.70) |
| Median CD4 T-cell counts [cell/μl (IQR)] | 294 (157-455) |
LPV/r, lopinavir/ritonavir; SGC, soft gel capsule; IQR, inter-quartile range.